Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cardia Adenocarcinoma”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Testing effectiveness (Phase 2)Study completedNCT00938470
What this trial is testing

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 73
Testing effectiveness (Phase 2)Study completedNCT00591123
What this trial is testing

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Who this might be right for
Unresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric Cardia+1 more
Translational Oncology Research International 38
Not applicableStudy completedNCT01295086
What this trial is testing

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Who this might be right for
Adenocarcinoma
Odense University Hospital 27
Large-scale testing (Phase 3)Looking for participantsNCT06028737
What this trial is testing

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerStomach CancerGastroEsophageal Cancer+13 more
Ukrainian Society of Clinical Oncology 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35
Not applicableStudy completedNCT01635595
What this trial is testing

Nodal Status in Adenocarcinoma of the Esophagus an Cardia

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastric Cardia
University of Bologna 194
Testing effectiveness (Phase 2)Study completedNCT00259987
What this trial is testing

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Who this might be right for
Adenocarcinoma
GlaxoSmithKline 24
Not applicableLooking for participantsNCT06702683
What this trial is testing

The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

Who this might be right for
Gastric CarcinomaGastric NeoplasmGastric (cardia, Body) Cancer+1 more
Lin Liu 112
Testing effectiveness (Phase 2)Study completedNCT00004127
What this trial is testing

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 35
Not applicableLooking for participantsNCT02491840
What this trial is testing

Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study

Who this might be right for
Gastric and Cardia Adenocarcinomas
University Hospital, Strasbourg, France 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT01512589
What this trial is testing

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 147
Testing effectiveness (Phase 2)Study completedNCT00003748
What this trial is testing

Irinotecan in Treating Patients With Esophageal or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 40
Not applicableStudy completedNCT04669951
What this trial is testing

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Who this might be right for
Esophagus Cancer, Adenocarcinoma
Michael Patrick Achiam 100
Not applicableStudy completedNCT02415101
What this trial is testing

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Karolinska University Hospital 202
Testing effectiveness (Phase 2)Study completedNCT00040859
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Study completedNCT02730546
What this trial is testing

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Who this might be right for
Gastric Cardia AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Gastric Cancer AJCC v7+5 more
Mayo Clinic 31
Not applicableUnknownNCT02741778
What this trial is testing

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Adenocarcinoma
Anhui Provincial Hospital 120
Not applicableStudy completedNCT01787864
What this trial is testing

Prevalence of Dysplasia of the Gastric Cardia

Who this might be right for
Barrett's EsophagusIntestinal MetaplasiaIntramucosal Adenocarcinoma
University of North Carolina, Chapel Hill 170
Testing effectiveness (Phase 2)Study completedNCT00107341
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 37
Large-scale testing (Phase 3)Looking for participantsNCT07000253
What this trial is testing

Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Who this might be right for
Esophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Load More Results